MHC-E-restricted CD8+ T cells target Hepatitis B virus-infected human hepatocytes

Currently 247 million people are living with chronic HBV infection (CHB), and the development of novel curative treatments is urgently needed. Immunotherapy is an attractive approach to treat CHB, yet therapeutic approaches to augment the endogenous HBV-specific T cell response in CHB patients have...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunol
Glavni autori: Burwitz, Benjamin J., Hashiguchi, Patrick K., Mansouri, Mandana, Meyer, Christine, Gilbride, Roxanne M., Biswas, Sreya, Womack, Jennie L., Reed, Jason S., Wu, Helen L., Axthelm, Michael K., Hansen, Scott G., Picker, Louis J., Früh, Klaus, Sacha, Jonah B.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109620/
https://ncbi.nlm.nih.gov/pubmed/32161099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1900795
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items